Serum Institute urges Mansukh Mandaviya to reduce gap between 2nd, precaution dose of Covishield from 9 to 3 months

Serum Institute has urged Union Health Minister Mansukh Mandaviya to consider reducing the gap between the second and the precaution dose of Covishield from current nine months to three, in line with Centre’s revised guidelines for officials on election duty, official sources said on Thursday. The Pune-based firm also requested the minister to allow it to administer Covishield’s precaution dose for all individuals aged above 18 years.

In a letter to Mandaviya, Prakash Kumar Singh, director, Government and Regulatory Affairs at SII, is learnt to stated that the third dose of COVID-19 vaccine is being administered within 6 months of the second dose in various countries and this schedule is giving very good results to control the infection, an official source said.

Singh also mentioned that private companies, educational institutions, social organisations, central government organisations as well as public undertaking companies etc are continuously requesting the firm for the third dose of Covishield for their staff members and families.

He referred to Union Health Ministry’s letter dated January 21 according to which the precaution dose can be administered 3 months after the second dose of the vaccine was given to officials and staff deployed on election duty in the poll-bound states of Goa, Manipur, Punjab, Uttarakhand and Uttar Pradesh.

For this, necessary changes have been made on the CoWIN portal to facilitate early administration of the precaution dose.

Till January 28, more than one crore people were administered the third dose of the COVID-19 vaccine out of which more than 90 lakh doses were of Covishield.

“In view of the above facts, we request for your kind intervention and consideration on our following submissions: The administration of third dose of our Covishield vaccine should be allowed for all individuals above the age of 18 years.

“The gap between second and third dose to be reduced and the administration of third dose of Covishield vaccine to be allowed after the completion of 3 months in line with revised guidelines of GoI for the officials and staff deployed on election duty,” the official source quoted Singh as having said in the letter.

“Sir, it is need of the hour and in the interest of public at large… This will help to control unpredictable and fast spread of various strains of COVID-19 which is disrupting economy and social stability of our country,” Singh said in the letter.

  • Related Posts

    • Pharma
    • June 18, 2025
    • 104 views
    Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

    Glenmark Pharmaceuticals said that the United States’ Food and Drug Administration (FDA) has concluded inspection of its manufacturing facility in Monroe, North Carolina. Glenmark Pharmaceuticals said that the United States’…

    • Pharma
    • June 18, 2025
    • 91 views
    ED conducts searches across six States in drug trafficking case

    The Enforcement Directorate on Tuesday conducted searches at 15 locations, including the premises of five pharmaceutical companies, across six States in connection with a drug trafficking case registered in Punjab.…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

    Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

    ED conducts searches across six States in drug trafficking case

    ED conducts searches across six States in drug trafficking case

    Gurugram: Teen dies after ‘friendly’ blow to chest; hospital role under scanner

    Gurugram: Teen dies after ‘friendly’ blow to chest; hospital role under scanner

    Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

    Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base